| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |